About the Esophageal Cancer Session
Esophageal cancer remains a challenging adversary in the realm of oncology, demanding innovative approaches in cancer research. Recent strides in understanding its molecular mechanisms have uncovered potential therapeutic targets, paving the way for precision medicine interventions. Immunotherapies, such as checkpoint inhibitors, show promise in bolstering the immune system's response against esophageal tumors, offering new avenues for treatment. Additionally, advancements in early detection techniques, like liquid biopsy and molecular imaging, hold the potential to improve patient outcomes by enabling timely intervention. Collaborative efforts between clinicians, researchers, and pharmaceutical companies are crucial in driving forward the development of novel therapies and diagnostic tools, ultimately enhancing the prognosis for individuals battling esophageal cancer.
Topics Covered in Esophageal Cancer
Squamous Cell Carcinoma
Esophageal Adenocarcinoma
Intestinal Metaplasia
Chemoradiotherapy
Esophagectomy Outcomes
Checkpoint Immunotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Esophageal Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Esophageal Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Esophageal Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Esophageal Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Esophageal Cancer Conference 2027 — FAQs
What is the Esophageal Cancer track at CIOC 2027?
The Esophageal Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Esophageal Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Esophageal Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Esophageal Cancer are all welcome — whether presenting or attending.
Can I present my research in the Esophageal Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Esophageal Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Esophageal Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.